Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Topoisomerases as Targets for Novel Drug DiscoveryAndrej Perdih
Current Medicinal Chemistry|March 7, 2018
Bioassays and In Silico Methods in the Identification of Human DNA Topoisomerase IIα InhibitorsKaja Bergant, Matej Janezic, Andrej Perdih
Current Pharmaceutical Design|February 1, 2013
Recent developments of DNA poisons--human DNA topoisomerase IIα inhibitors--as anticancer agentsBarbara Pogorelčnik, Andrej Perdih, Tom Solmajer
International Journal of Molecular Sciences|July 2, 2021
Nonameric Peptide Orchestrates Signal Transduction in the Activating HLA-E/NKG2C/CD94 Immune Complex as Revealed by All-Atom SimulationsEva Prašnikar, Andrej Perdih, Jure Borišek
Ageing Research Reviews|January 1, 2021
Senescent cells as promising targets to tackle age-related diseasesEva Prašnikar, Jure Borišek, Andrej Perdih
Journal of Computer-Aided Molecular Design|August 31, 2013
Molecular dynamics simulation and linear interaction energy study of D-Glu-based inhibitors of the MurD ligaseAndrej Perdih, Gerhard Wolber, Tom Solmajer
Journal of Chemical Information and Modeling|July 1, 2021
All-Atom Simulations Reveal a Key Interaction Network in the HLA-E/NKG2A/CD94 Immune Complex Fine-Tuned by the Nonameric PeptideEva Prašnikar, Andrej Perdih, Jure Borišek
Pageof 7